Cancer Center of Middle Georgia is a clinical research site located in Dublin, Georgia, United States 31021.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Cancer Center of Middle Georgia has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Pain, Peripheral Neuropathy, Neuropathic Pain.
Sponsors: Wex Pharmaceuticals Inc., Caris Science, Inc., Spectrum Pharmaceuticals, Inc.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cancer Center of Middle Georgia has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cancer Center of Middle Georgia has 6 clinical trials on record, with 3 currently active. Their work covers Pain, Peripheral Neuropathy, Neuropathic Pain.
Yes — Cancer Center of Middle Georgia holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.